Japanese
Title乳癌病期分類および経過観察における骨スキャンの臨床的検討
Subtitle原著
Authors洪誠秀*, 磯辺靖*, 岡野滋樹**, 津屋旭*, 宍戸文男***, 金田浩一*, 杉山丈夫*, 早川和重**, 井口博善*, 徳元善昭****, 高橋清治*****, 野村悦司*****, 山田康彦*****, 矢部仁*****, 梅垣洋一郎*
Authors(kana)
Organization*癌研究会附属病院放射線科, **神奈川県立子供医療センター放射線科, ***放射線医学総合研究所臨床研究部, ****徳島大学医学部放射線科, *****癌研究会附属病院アイソトープ部
Journal核医学
Volume19
Number6
Page863-869
Year/Month1982/7
Article原著
Publisher日本核医学会
Abstract「要旨」1978年1月から1980年7月までの31か月間に, 乳癌患者に施行された骨スキャン1,122件の陽性率および検出能を解析することにより, 乳癌診療における骨スキャンの位置と役割を検討した. 骨スキャン陽性率は, 治療開始後3か月以内ですでに16.6%もあり, それ以降も経過するに従い上昇した. 正確な病期分類, 骨転移の早期発見のためには, 骨スキャンはさらに積極的に施行されるべきだと思われた. 検出能を検討した結果false positive rateは10.2%, false negative rateは1.5%と算出された. この値から, 骨スキャンはあくまでスクリーニングのための検査であり, スキャン陽性はさらに確認のための検査が必要と思われた. 骨スキャンは, 乳癌病期分類および経過観察において必須のスクリーニング検査であり, 治療前および治療後定期的に施行されるべきである.
Practice臨床医学:一般
KeywordsBone scintigraphy, Metastatic bone tumor, Breast carcinoma.
English
TitleClinical Evaluation of Pretreatment and Follow-up Bone Scans in Patients with Breast Cancer
Subtitle
AuthorsSeong Su HONG*, Yasushi ISOBE*, Shigeki OKANO**, Akira TSUYA*, Fumio SHISHIDO***, Koichi KANETA*, Takeo SUGIYAMA*, Kazushige HAYAKAWA*, Hiroyoshi IGUCHI*, Yoshiaki TOKUMOTO****, Seiji TAKAHASHI*****, Etsuji NOMURA*****, Yasuhiko YAMADA*****, Hitoshi YABE*****, Yoichiro UMEGAKI*
Authors(kana)
Organization*Department of Radiology, Cancer Institute Hospital, **Department of Radiology, Kanagawa Childrens Medical Centor, ***Division of Clinical Research, National Institute of Radiological Sciences, ****Department of Radiology, Tokushima University, *****Division of Nuclear Medicine, Cancer Institute Hospital
JournalThe Japanese Journal of nuclear medicine
Volume19
Number6
Page863-869
Year/Month1982/7
ArticleOriginal article
PublisherTHE JAPANESE SOCIETY OF NUCLEAR MEDICINE
Abstract[Summary]Consecutive 1122 bone scans performed on 865 patients with breast cancer during the 31 months from January 1978 to July 1980 were analyzed, and the role of bone scan in the management of breast cancer was examined. Scan positive rate was 16.6% within 3 months after initial treatment, and gradually increased thereafter. It was considered that bone scanning should be performed more frequently for strict staging or for early detection of bone metastasis. False positive rate of bone scan was calculated at 10.2%, and false negative rate was 1.5%. Therefore, bone scan may be regarded as a test for screening, and while negative scans may well be decided as no bone lesions, abnormal scans should be further examined to confirm true diagnosis. On the understanding of these properties, bone scan is considered as an indispensable tool for staging and follow-up study in patients with breast cancer, and it should be performed before initial treatment and periodically for post-treatment follow-up.
PracticeClinical medicine
KeywordsBone scintigraphy, Metastatic bone tumor, Breast carcinoma.

【全文PDF】